Why Teva Pharmaceuticals can dodge rivals' pain
Teva Pharmaceuticals has none of the controversial aspects that have hit rivals.
Telstra to create national cancer register
Telstra has secured $220 million government contract to build the Australian National Cancer Screening Register, a task that the Department of Human Services is understood to have told the government it did not had the capacity to deliver.
Programmed shares surge
Painting, repairs and laying turf are picking up where the mining boom fades, pushing up Programmed shares by 13 per cent.
New hope for potency after prostate surgery
A combination of implanted radiated seeds and external beam radiation appears to show promise in preserving a man's potency after prostate surgery.
US approves CSL flu vaccine
Biopharma company CSL has received US regulatory approval for a formulation of its Flucelvax Quadrivalent influenza vaccine.
Aged care operator Allity ahead of Estia, Bupa in race for Croft portfolio
While Street Talk understands Bupa, ASX-listed Estia Health and other private equity firms have also held negotiations with Croft over the p...
Sydney Hotspots: health spend boosts Kogarah
Even Sydney has suburbs with affordable property that are about rise in value as a result of planned infrastructure spend.
Shorten's $8b drag on budget
Labor's major promises will cost $8 billion over the next four years, raising the prospect it could leave the budget worse off in the short ...
Telstra robots transmit a doctor's touch from city to country
Remote ultrasound robots backed by Telstra allow city doctors to treat country patients.
Labor's Medicare plan for the AMA, not patients
Unfortunately, Labor's "positive policy for a stronger Medicare" is all about currying favour with the doctors' union.
